Intrinsiqs

Is Replimune Group, Inc. overvalued?

Replimune Group, Inc. (REPL) — key valuation metrics and fundamentals.

No verdict
Price
$12.56
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.06B
Dividend yield
0.0%
Return on equity
-159.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares REPL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.